Letter to the editor in response to: A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children
Expert Rev Vaccines
.
2022 Dec;21(12):1929.
doi: 10.1080/14760584.2022.2143624.
Epub 2022 Nov 18.
Authors
Kristen Feemster
1
,
Natalie Banniettis
2
,
Ulrike K Buchwald
2
Affiliations
1
Global Medical and Scientific Affairs, Pneumococcal Vaccines, Merck Research Laboratories, Merck & Co., Inc, USA.
2
Global Clinical Development, Pneumococcal Vaccines, Merck Research Laboratories, Merck & Co., Inc., USA.
PMID:
36399414
DOI:
10.1080/14760584.2022.2143624
No abstract available
Publication types
Systematic Review
Research Support, Non-U.S. Gov't
MeSH terms
Child
Humans
Pneumococcal Infections* / prevention & control
Vaccines, Conjugate
Substances
Vaccines, Conjugate